Abstract
Primary endothelial dystrophy of the cornea is a fairly common disease in people older than 50 years. Well-developed methods of conservative treatment, as a rule, do not lead to improvement or stabilization of the functional state of the cornea. The choice of tactics of surgical treatment from the existing variety of techniques is complicated. There are isolated reports of the restoration of corneal transparency after descemet membrane removal. The author's method of endothelial corneal dystrophy treatment addressed in this particular clinical case a combination of isolated descemetorhexis and collagen cross-linking resulted in impressive increase in visual acuity and significant improvement in objective criteria for the morpho-functional state of the cornea.
Highlights
Первичная эндотелиальная дистрофия роговицы достаточно распространённое заболевание у лиц старше 50 лет
The author's method of endothelial corneal dystrophy treatment addressed in this particular clinical case – a combination of isolated descemetorhexis and collagen cross-linking – resulted in impressive increase in visual acuity and significant improvement in objective criteria for the morpho-functional state of the cornea
ВВЕДЕНИЕ Выбор метода лечения эндотелиальной дистрофии (ЭД) роговицы всегда сложен, и, как правило, приоритет остаётся за кератопластикой
Summary
Первичная эндотелиальная дистрофия роговицы достаточно распространённое заболевание у лиц старше 50 лет. ABOUT A NEW APPROACH TO SURGICAL TREATMENT OF CORNEAL ENDOTHELIAL DYSTROPHY For citation: Astakhov SYu, Riks IA, Papayan SS, et al About a new approach to surgical treatment of corneal endothelial dystrophy. The author's method of endothelial corneal dystrophy treatment addressed in this particular clinical case – a combination of isolated descemetorhexis and collagen cross-linking – resulted in impressive increase in visual acuity and significant improvement in objective criteria for the morpho-functional state of the cornea.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
